Teva Fights Class Cert. Bid In Effexor Antitrust Case
By George Woolston · February 4, 2026, 6:21 PM EST
Teva Pharmaceuticals urged a New Jersey federal judge Wednesday to reject a class certification bid by a group of direct buyers of the antidepressant drug Effexor XR and its generic versions,...
To view the full article, register now.